To develop the new feline quality of life (FelQoL) questionnaire, the researchers used data from 1,324 cat owners in the United States and the United Kingdom...
New findings show hair loss affecting more young people in APAC...
Alongside its strategic investment, Shrem will also partner with Emoha to establish Shremoha...
First and only melanoma gene expression profiling test that is both designated as an FDA Breakthrough Device and included in the NCCN guidelines for T1b and T2a cutaneous melanoma patients...
The two ProteusONE systems will be the first proton therapy systems in the country and will serve as the National Proton Therapy Centre of Portugal...
Dr Panchal explains how healthcare organisations can deploy AI responsibly without diminishing physician oversight...
ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer’s Diagnosis at Global Scale ...
The initiative will support placement of VMS+ cardiac imaging units to improve congenital heart disease assessment in underserved settings....
The CIZ1B biomarker test is being prepared for near-term availability to U.S. healthcare providers through OmniHealth Diagnostics....
The Xpert Hemorrhagic Fever panel will support decentralised molecular testing during the Ebola Bundibugyo outbreak in DRC and Uganda....
